As a C class chemokine, XCL1 has been found to play a key role in anti-tumor immune response in the recent years.12 Here, our findings were consistent with previous studies, suggesting that the expression of XCL1 has been positively related to CD8+ T cells and NK cells. This evidence concerns the gene CD8A and neoplasm.